Ovarian cancer has seen a significant shift in its treatment paradigm with the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, which are now standard in the maintenance setting ...

BERLIN--(BUSINESS WIRE)--Bayer today announced positive topline results of the Phase III study OASIS 4 investigating elinzanetant as non-hormonal treatment for moderate to severe vasomotor ...

SINGAPORE - The quality of teachers is a greater determinant of educational outcomes than class size, said Education Minister Chan Chun Sing. Though some suggest that hiring more teachers would ...

This guidance document applies to T&Cs imposed on Class II to IV medical device licences under subsection 36(2) of the MDR. It explains the purpose of T&Cs and outlines the process that will be ...

MPPKVVCL has begun recruitment for Class III and Class IV positions on a regular basis in the successor companies of the erstwhile MPSEB. The 2,573 vacancies include roles such as Office Assistant ...

The $5 price tag doesn’t hurt too much either. The quick-drying and low-maintenance formula was very well-received among reviewers who corroborated the brand’s claims that the treatment offers visible ...

A family from Hillingdon are celebrating what they call the "best Christmas present they could ask for", after their four-year-old son finished his leukaemia treatment. Noah Karunananthan and his ...

Dennis Madamba / Investopedia The middle class is a socioeconomic category used to describe people and families with incomes that fall into the median range for the geographic area they live in.

The development candidate (“PD-29875”) is a novel first-in-class ... the therapeutic (225 Ac-PD-29875) and paired diagnostic imaging agent (64 Cu-PD-29875) for the diagnosis and treatment ...

Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug ...